Target Name: ZKSCAN7
NCBI ID: G55888
Review Report on ZKSCAN7 Target / Biomarker Content of Review Report on ZKSCAN7 Target / Biomarker
ZKSCAN7
Other Name(s): Zinc finger protein with KRAB and SCAN domains 7 (isoform 1) | ZNF64 | zinc finger protein 167 | ZFP | Zinc finger protein with KRAB and SCAN domains 7 | ZNF448 | ZKSCAN7 variant 1 | Zinc finger with KRAB and SCAN domains 7, transcript variant 1 | zinc finger protein 448 | ZKSC7_HUMAN | ZNF167 | Zinc finger protein 64 | zinc finger with KRAB and SCAN domains 7 | Zinc finger with KRAB and SCAN domains 7 | Zinc finger protein 167 | zinc finger protein 64 | Zinc finger protein 448 | ZSCAN39

ZKSCAN7: A Potential Drug Target and Biomarker

Zinc finger proteins (ZFPs) are a family of non-coding RNAs that play a crucial role in various cellular processes. ZKSCAN7, a 7-kDa ZFP, has been identified as a potential drug target and biomarker. In this article, we will discuss the ZKSCAN7 protein, its functions, potential drug targets, and its potential as a biomarker for various diseases.

Structure and Function

The ZKSCAN7 protein is composed of 194 amino acid residues, including a N-terminal KRAB domain, a SCAN domain, and a C-terminal TAD domain. The KRAB domain is a type of transmembrane protein that contains a zinc finger and a carboxy-terminal domain. The SCAN domain is a nucleotide-binding domain that contains a specific amino acid sequence that is involved in protein-protein interactions. The TAD domain is a nucleotide-binding domain that contains a specific amino acid sequence that is involved in protein-protein interactions. interactions.

ZKSCAN7 is a secreted protein that is expressed in various tissues and organs, including brain, heart, liver, and muscle. It has been shown to play a role in various cellular processes, including cell signaling, DNA replication, and cell survival. ZKSCAN7 has has also been shown to interact with various protein partners, including histone modifications, non-coding RNAs, and other ZFPs.

Potential Drug Target

The zinc finger domains of ZKSCAN7 make it a potential drug target. Zinc finger proteins have been shown to play a role in various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. ZKSCAN7 is thought to be involved in the regulation of cellular processes that are relevant to these diseases, including cell signaling, DNA replication, and cell survival.

Drugs that target ZKSCAN7 have been shown to have therapeutic effects in various animal models of disease. For example, studies have shown that inhibitors of ZKSCAN7 can reduce the growth of cancer cells and improve the survival of neurodegenerative disease model animals. Additionally, inhibitors of ZKSCAN7 have been shown to improve the expression of apoptosis genes, suggesting that they may have a role in the regulation of cell death.

Biomarker Potential

ZKSCAN7 has also been shown to be a potential biomarker for various diseases. The expression and distribution of ZKSCAN7 have been shown to be altered in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. Additionally, studies have shown that the expression of ZKSCAN7 is associated with the development of certain diseases, such as neurodegenerative disease.

Conclusion

In conclusion, ZKSCAN7 is a protein that has been identified as a potential drug target and biomarker. Its functions and potential drug targets are being further explored in order to understand its role in various diseases. Further research is needed to determine the exact mechanisms by which ZKSCAN7 interacts with its protein partners and to develop effective drugs that target ZKSCAN7.

Protein Name: Zinc Finger With KRAB And SCAN Domains 7

Functions: May be involved in transcriptional regulation

The "ZKSCAN7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZKSCAN7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZKSCAN8 | ZKSCAN8P1 | ZMAT1 | ZMAT2 | ZMAT3 | ZMAT4 | ZMAT5 | ZMIZ1 | ZMIZ1-AS1 | ZMIZ2 | ZMPSTE24 | ZMYM1 | ZMYM2 | ZMYM3 | ZMYM4 | ZMYM4-AS1 | ZMYM5 | ZMYM6 | ZMYND10 | ZMYND11 | ZMYND12 | ZMYND15 | ZMYND19 | ZMYND8 | ZNF10 | ZNF100 | ZNF101 | ZNF106 | ZNF107 | ZNF112 | ZNF114 | ZNF117 | ZNF12 | ZNF121 | ZNF124 | ZNF131 | ZNF132 | ZNF133 | ZNF134 | ZNF135 | ZNF136 | ZNF137P | ZNF138 | ZNF14 | ZNF140 | ZNF141 | ZNF142 | ZNF143 | ZNF146 | ZNF148 | ZNF154 | ZNF155 | ZNF157 | ZNF16 | ZNF160 | ZNF165 | ZNF169 | ZNF17 | ZNF174 | ZNF175 | ZNF177 | ZNF18 | ZNF180 | ZNF181 | ZNF182 | ZNF184 | ZNF185 | ZNF189 | ZNF19 | ZNF195 | ZNF197 | ZNF2 | ZNF20 | ZNF200 | ZNF202 | ZNF204P | ZNF205 | ZNF205-AS1 | ZNF207 | ZNF208 | ZNF209P | ZNF211 | ZNF212 | ZNF213 | ZNF213-AS1 | ZNF214 | ZNF215 | ZNF217 | ZNF219 | ZNF22 | ZNF22-AS1 | ZNF221 | ZNF222 | ZNF223 | ZNF224 | ZNF225 | ZNF225-AS1 | ZNF226 | ZNF227 | ZNF229